Appeals court wants limits on abortion pill access, sending case to Supreme Court
Headline from ABC 30 Fresno
The abortion drug mifepristone should be more tightly regulated, the 5th U.S. Circuit Court of Appeals says in a ruling that now heads to the Supreme Court.
ABC 30 Fresno's own description from its feed. We collect headlines and these descriptions, not full articles; read the original reporting below.
Today, a three-judge panel of the Fifth Circuit Court of Appeals issued a decision in Alliance for Hippocratic Medicine et al v. U.S. Food and Drug Administration et al, the baseless case challenging the FDA’s approval of mifepristone, a safe and effective drug used in over half of all U.S.
A US appeals court on Wednesday ruled access to the abortion pill should be preserved with some limits, rejecting part of an order from a judge in Texas that would have effectively banned the sale of the drug across the country.
A federal appeals court on Wednesday ruled to restrict some access to the abortion pill mifepristone, partially keeping a lower court ruling intact that would fully revoke federal approval.
The Supreme Court has ruled that mifepristone, a key abortion drug, will remain available for now under existing regulations while the litigation continues.
Mail-order access to a drug used in the most common form of abortion in the U.S. would end under a new federal appeals court ruling . However, the ruling issued
A US federal appeals court on Wednesday imposed restrictions on a widely used abortion pill, but the ruling will remain on hold as the Supreme Court decides whether to hear the case.
The abortion drug mifepristone should be more tightly regulated, the 5th U.S. Circuit Court of Appeals says in a ruling that now heads to the Supreme Court.
A federal appeals court upheld the 23-year-old approval of mifepristone, but said a series of actions the FDA took in recent years to make it easier to obtain went too far.
A federal appeals court would restrict the use of mifepristone, a pill used in medication abortions. But previous action by the Supreme Court means the status quo holds for now.
A federal appeals court on Wednesday wiped away a lower court’s ruling that would’ve taken the medication abortion drug mifepristone off the market, but upheld aspects of the ruling that could cut back access to the pills.
A U.S. 5th Circuit Court of Appeals panel upheld restrictions on the abortion pill mifepristone, finding that the FDA didn't take safety concerns into account when making the pill more accessible.
A federal appeals court ruled Wednesday that the abortion pill can remain on the market, though the judges halted recent moves to expand access, such as the Biden administration’s plan to make it available to women through the mail.
